glp-1 for addiction treatment medications get at the heart of addiction: study – WashU Medicine GLP-1 Medications Show Promise as
Description
Many patients including those treated at Potere Health MD report that tirzepatide feels smoother and that side effects are easier to tolerate once they reach the right dose
When the study group was stratified by BMI, adults without obesity, those with class I obesity (BMI: 30-34.99 kg/m2) and those with class II obesity (BMI: 35-39.99 kg/m2) were less likely to have all-cause hospital admissions, ED visits, undergo an endoscopic procedure, receive a prescription for a prokinetic, and receive a laxative prescription if they used an incretin-based drug compared with nonusers
They began spacing out the shots instead of injecting themselves every week
Built on several decades of successful experience, its staff provide international expertise on research and policy analysis, inter-governmental consensus-building, and technical assistance to over 150 countries
GLP1 medications are peptide therapies that mimic (or enhance) gutbrain signaling involved in appetite, satiety, and glucose regulation
doi: 10.1038/s41467-020-14309-w 24 IshibashiYMatsuiTTakeuchiMYamagishiS
